121 related articles for article (PubMed ID: 37934100)
1. Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
Jiang H; Yang C; Chen Y; Wang Y; Wu Y; Chen W; Ronot M; Chernyak V; Fowler KJ; Bashir MR; Song B
Radiology; 2023 Nov; 309(2):e230527. PubMed ID: 37934100
[TBL] [Abstract][Full Text] [Related]
2. Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid-enhanced MRI: risk scoring system development and validation.
Park SH; Kim B; Kim S; Park S; Park YH; Shin SK; Sung PS; Choi JI
Eur Radiol; 2023 May; 33(5):3566-3579. PubMed ID: 36933020
[TBL] [Abstract][Full Text] [Related]
3. Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma.
Jiang H; Qin Y; Wei H; Zheng T; Yang T; Wu Y; Ding C; Chernyak V; Ronot M; Fowler KJ; Chen W; Bashir MR; Song B
Eur Radiol; 2023 Oct; ():. PubMed ID: 37870624
[TBL] [Abstract][Full Text] [Related]
4. Preoperative prediction of cholangiocyte phenotype hepatocellular carcinoma on contrast-enhanced MRI and the prognostic implication after hepatectomy.
Chen Y; Chen J; Yang C; Wu Y; Wei H; Duan T; Zhang Z; Long L; Jiang H; Song B
Insights Imaging; 2023 Nov; 14(1):190. PubMed ID: 37962669
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
6. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
Kang HJ; Kim H; Lee DH; Hur BY; Hwang YJ; Suh KS; Han JK
Radiology; 2021 Sep; 300(3):572-582. PubMed ID: 34227881
[TBL] [Abstract][Full Text] [Related]
7. VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
Jiang H; Wei H; Yang T; Qin Y; Wu Y; Chen W; Shi Y; Ronot M; Bashir MR; Song B
Radiology; 2023 Apr; 307(2):e221835. PubMed ID: 36786702
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
10. Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival.
Kim DK; An C; Chung YE; Choi JY; Lim JS; Park MS; Kim MJ
Radiology; 2019 Dec; 293(3):594-604. PubMed ID: 31592730
[TBL] [Abstract][Full Text] [Related]
11. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
[TBL] [Abstract][Full Text] [Related]
12. Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
Iseke S; Zeevi T; Kucukkaya AS; Raju R; Gross M; Haider SP; Petukhova-Greenstein A; Kuhn TN; Lin M; Nowak M; Cooper K; Thomas E; Weber MA; Madoff DC; Staib L; Batra R; Chapiro J
AJR Am J Roentgenol; 2023 Feb; 220(2):245-255. PubMed ID: 35975886
[No Abstract] [Full Text] [Related]
13. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
Youn SY; Kim B; Kim DH; Choi HJ; Sung PS; Choi JI
Eur Radiol; 2022 Sep; 32(9):6270-6280. PubMed ID: 35348864
[TBL] [Abstract][Full Text] [Related]
14. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
[TBL] [Abstract][Full Text] [Related]
15. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
[TBL] [Abstract][Full Text] [Related]
16. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
[TBL] [Abstract][Full Text] [Related]
17. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
[TBL] [Abstract][Full Text] [Related]
18. CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
Feng Z; Li H; Liu Q; Duan J; Zhou W; Yu X; Chen Q; Liu Z; Wang W; Rong P
Radiology; 2023 Apr; 307(1):e221291. PubMed ID: 36511807
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement as a risk factor for late recurrence (>1 year) of hepatocellular carcinoma after surgery.
Matsuda M; Ichikawa S; Matsuda M; Amemiya H; Ichikawa D; Onishi H; Motosugi U
Clin Radiol; 2019 Dec; 74(12):975.e1-975.e9. PubMed ID: 31540704
[TBL] [Abstract][Full Text] [Related]
20. Targetoid Primary Liver Malignancy in Chronic Liver Disease: Prediction of Postoperative Survival Using Preoperative MRI Findings and Clinical Factors.
Park SH; Heo S; Kim B; Lee J; Choi HJ; Sung PS; Choi JI
Korean J Radiol; 2023 Mar; 24(3):190-203. PubMed ID: 36788766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
